X0306 4 2017-12-19 0 0001371217 ReShape Lifesciences Inc. RSLS 0001642607 Mashaal Michael Y 2800 PATTON ROAD ST. PAUL MN 55113 1 0 0 0 Common Stock, $0.01 par value per share 2017-12-19 4 C 0 2048700 A 2617077 I See footnote Series C Convertible Preferred Stock, $0.01 par value 2017-12-19 4 S 0 20487 D 26200 I See footnote Each share of Series C Convertible Preferred Stock converted into 100 shares of common stock. Consists of shares held directly by HealthCor Partners Fund II, L.P. ("HCPII"). The shares held by HCPII may be deemed to be beneficially owned by HealthCor Partners II, L.P. ("HCP2LP"), its general partner, and by HealthCor Partners GP, LLC ("HCPGP"), the general partner of HCP2LP. Dr. Mashaal is a managing director of HealthCor Partners Management, L.P. ("HCP Management"), which is the investment manager to HCPII, and may be deemed to have shared voting and investment power over such shares. Each of HCPLP, HCP2LP, HCPGP, HCP Management and Dr. Mashaal hereby disclaims any beneficial ownership of shares held by HCPII except to the extent of any pecuniary interest therein. /s/ Scott P. Youngstrom, attorney-in-fact 2017-12-21